Skip to content

Measuring the Effects of Pharmacological Compounds on Mitochondrial Morphology in Mouse Aging Models.

Aug 2026 · Journal of Visualized Experiments · Vol 234 · 0 citations
Medicine

TL;DR

Methods for performing subcutaneous osmotic pump implantations in aged mice for the stable delivery of hydrophobic pharmacological compounds and an automated pipeline for the three-dimensional segmentation, classification, and quantitative measurement of mitochondrial structures may be useful for quantitatively assessing changes in mitochondrial three-dimensional structure in different tissues across the mouse lifespan.

Abstract

Aging-related molecular damage accumulation can contribute to changes in mitochondrial morphology and metabolic dysfunction, particularly in tissues with high energy expenditures. Pharmacological compounds that ameliorate metabolic dysfunction and restore healthy, 'young' mitochondrial morphologies may thus represent effective modalities to extend healthspan (i.e., the portion of one's lifespan free from the burden of aging-related chronic disease) in mammals. Herein, methods for performing subcutaneous osmotic pump implantations in aged mice for the stable delivery of hydrophobic pharmacological compounds are described. Then, tissues are fixed, cryosectioned, stained, and imaged using super-resolution confocal light microscopy. Finally, an automated pipeline for the three-dimensional segmentation, classification, and quantitative measurement of mitochondrial structures is presented. Thus, these methods may be useful for quantitatively assessing changes in mitochondrial three-dimensional structure in different tissues across the mouse lifespan. Moreover, these techniques may aid in the reproducible identification of small-molecule drugs that mitigate aging-related metabolic dysfunction.

View source

Similar papers

Open access Aug 2026

Mitochondrial dysfunction as a hallmark of brain senescence in telomerase-deficient mice

A major consequence of telomere dysfunction associated with pathological brain aging is the downregulation of mitochondrial activity, which contributes to the selective vulnerability of specific brain regions, highlighting mitochondrial pathways as attractive targets for interventions aimed at preserving brain health d...

Debora Palomares, Joana Jorgji, Shirine Saleki et al. · 0 citations
Review Aug 2026

The organellar biology of aging: A mitochondrial vantage

More research in the field may unravel the mechanistic details of the organellar crosstalk that works in concert with classical aging pathways to sustain aging progression, which may help promote healthier aging.

Madhusmita Pala, Abinash Nayak, Bandita Rath · 0 citations
Review Open access Sep 2026

Mitochondrial Fusion and Fission in Age‐Related Cardio‐Cerebral Diseases: Mechanisms and Interventions

Recent research on alterations in mitochondrial dynamics in age‐related cardio‐cerebral diseases are summarized and therapeutic strategies targeting these alterations are explored, which may offer new directions for improving cardiac and brain health and guiding clinical practice.

Yu-Yao Yin, Zi-Jian Li · 0 citations
Review Open access Sep 2026

The Hallmarks of Aging: From Molecular Mechanisms to Clinical Translation

This work evaluates the mechanistic and translational evidence for all twelve hallmarks of aging framework and examines RNA-processing defects and extracellular matrix remodeling as candidate processes without classifying either as an additional hallmark.

P. Chmielewski, Bartłomiej Strzelec · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.